Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04045821 · ClinicalTrials.gov registry record · NA
Endometrial Rejuvenation Study
A NA study, sponsored by Reproductive Medicine Associates of New Jersey.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT04045821 is a NA study that was terminated before completion, run by Reproductive Medicine Associates of New Jersey. The registered enrollment target is 3 participants.
The verdict
NCT04045821, a NA study, was terminated before completion, sponsored by Reproductive Medicine Associates of New Jersey.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
To evaluate the response of the endometrial lining after subcutaneous administration of the medication AMD3100. This medication mobilizes stem cells and will be used in a population of infertile women with a thin endometrium who are undergoing frozen-thawed embryo transfer. The investigators will assess associations between response to stem cell mobilization and pregnancy outcomes.
Interventions
- DRUG Normal saline
- DRUG AMD3100
- PROCEDURE dilation and curettage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2020-01-17 |
| Est. Completion | 2021-05-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04045821
The ClinicalTrials.gov registry entry for NCT04045821 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Reproductive Medicine Associates of New Jersey, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Normal saline is the first listed.
NCT04045821 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04045821 about?
NCT04045821 is a clinical study titled "Endometrial Rejuvenation Study". To evaluate the response of the endometrial lining after subcutaneous administration of the medication AMD3100. This medication mobilizes stem cells and will be used in a population of infertile women with a thin endometrium who are undergoing frozen-thawed embryo transfer. The investigators will as...
What is the current status of trial NCT04045821?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2020-01-17. Estimated completion is 2021-05-04.
What interventions are being tested in trial NCT04045821?
The interventions under investigation include: Normal saline (DRUG), AMD3100 (DRUG), dilation and curettage (PROCEDURE).
Who is sponsoring clinical trial NCT04045821?
This trial is sponsored by Reproductive Medicine Associates of New Jersey, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.